Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Microglial cerebrospinal fluid antibodies. Significance for Alzheimer disease.

McRae A, Ling EA, Wigander A, Dahlström A.

Mol Chem Neuropathol. 1996 May-Aug;28(1-3):89-95.

PMID:
8871946
2.

Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies.

Dahlström A, McRae A, Polinsky R, Nee L, Sadasivan B, Ling EA.

Mol Neurobiol. 1994 Aug-Dec;9(1-3):41-54.

PMID:
7888106
3.

Cerebrospinal fluid microglial antibodies: potential diagnostic markers for immune mechanisms in Alzheimer's disease.

McRae A, Dahlström A, Polinsky R, Ling EA.

Behav Brain Res. 1993 Nov 30;57(2):225-34. Review.

PMID:
8117427
4.

Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease.

McRae A, Dahlström A, Ling EA.

Gerontology. 1997;43(1-2):95-108. Review.

PMID:
8996832
5.
6.

Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process.

McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J.

Exp Gerontol. 2007 Apr;42(4):355-63. Epub 2006 Nov 30.

PMID:
17140756
7.

Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.

McIntyre JA, Chapman J, Shavit E, Hamilton RL, Dekosky ST.

Autoimmunity. 2007 Jul;40(5):390-6.

PMID:
17612901
8.

Properties of activated microglia and pharmacologic interference by propentofylline.

McRae A, Ling EA, Schubert P, Rudolphi K.

Alzheimer Dis Assoc Disord. 1998;12 Suppl 2:S15-20.

PMID:
9769025
9.
10.

Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.

Di Domenico F, Pupo G, Giraldo E, Lloret A, Badia MC, Schinina ME, Giorgi A, Butterfield DA, Vina J, Perluigi M.

Curr Alzheimer Res. 2016;13(2):112-22.

PMID:
26679861
11.

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.

Gómez-Tortosa E, Gonzalo I, Fanjul S, Sainz MJ, Cantarero S, Cemillán C, Yébenes JG, del Ser T.

Arch Neurol. 2003 Sep;60(9):1218-22.

PMID:
12975286
12.

Propentosylline depresses amyloid and Alzheimer's CSF microglial antigens after ischaemia.

McRae A, Rudolphi KA, Schubert P.

Neuroreport. 1994 Jun 2;5(10):1193-6.

PMID:
7919163
13.
14.
15.

Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid.

Loeffler DA, Juneau PL, Nguyen HU, Najman D, Pomara N, LeWitt PA.

Neurochem Res. 1997 Feb;22(2):209-14.

PMID:
9016847
16.

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD.

Exp Neurol. 2001 Sep;171(1):29-45.

PMID:
11520119
17.

Microglial pathology.

Streit WJ, Xue QS, Tischer J, Bechmann I.

Acta Neuropathol Commun. 2014 Sep 26;2:142. doi: 10.1186/s40478-014-0142-6. Review.

18.

Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament.

Bartos A, Fialová L, Svarcová J, Ripova D.

J Neuroimmunol. 2012 Nov 15;252(1-2):100-5. doi: 10.1016/j.jneuroim.2012.08.001. Epub 2012 Sep 2.

PMID:
22948089
19.

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Månsson JE, Johansson JO, Olsson B, Wallin A, Svensson J, Blennow K, Zetterberg H.

Neuromolecular Med. 2011 Jun;13(2):151-9. doi: 10.1007/s12017-011-8147-9. Epub 2011 May 13.

PMID:
21567187
20.

Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.

Costa A, Bini P, Hamze-Sinno M, Moglia A, Franciotta D, Sinforiani E, Ravaglia S, Bole-Feysot C, Hökfelt T, Déchelotte P, Fetissov SO.

J Neuroimmunol. 2011 Dec 15;240-241:114-20. doi: 10.1016/j.jneuroim.2011.10.003. Epub 2011 Nov 10.

PMID:
22078238

Supplemental Content

Support Center